Author:
Mohanty Debajani,Padhee Sucheesmita,Priyadarshini Arpita,Champati Bibhuti Bhusan,Das Prabhat Kumar,Jena Sudipta,Sahoo Ambika,Chandra Panda Pratap,Nayak Sanghamitra,Ray Asit
Reference77 articles.
1. The biology and management of non-small cell lung cancer;Herbst;Nature,2010
2. Molecular docking study of sea urchin (Arbacia lixula) peptides as multi-target inhibitor for non-small cell lung cancer (NSCLC) associated proteins;Widyananda;J Pharm Pharmacogn Res,2021
3. Using network pharmacology and molecular docking to explore the mechanism of Shan Ci Gu (Cremastra appendiculata) against non-small cell lung cancer;Wang;Front. Chem.,2021
4. Integrated network pharmacology and in-silico approaches to decipher the pharmacological mechanism of Selaginella tamariscina in the treatment of non-small cell lung cancer;Kumar;Phytomed. plus.,2023
5. Inhibition effect of oxyepiberberine isolated from Coptis chinensis franch. on non-small cell lung cancer based on a network pharmacology approach and experimental validation;Zhang;J. Ethnopharmacol.,2021
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献